Clinical and Laboratory Predictors of Shiga Toxin-Producing Escherichia coli Infection in Children With Bloody Diarrhea
- PMID: 29617871
- PMCID: PMC6097574
- DOI: 10.1093/jpids/piy025
Clinical and Laboratory Predictors of Shiga Toxin-Producing Escherichia coli Infection in Children With Bloody Diarrhea
Abstract
Objectives: Children with acute bloody diarrhea are at risk of being infected with Shiga toxin-producing Escherichia coli (STEC) and of progression to hemolytic uremic syndrome. Our objective was to identify clinical and laboratory factors associated with STEC infection in children who present with acute bloody diarrhea.
Methods: We performed a prospective cohort study of consecutive children younger than 18 years who presented with acute (<2-week duration) bloody diarrhea between August 1, 2013, and August 1, 2014. We excluded patients with a chronic gastrointestinal illness and/or an obvious noninfectious source of bloody stool. We obtained a standardized history and study laboratory tests, performed physical examinations, and recorded patient outcomes.
Results: Of the 135 eligible patients, 108 were enrolled; 27 declined consent. The median patient age was 3 years, and 56% were male. Ten (9%) patients tested positive for STEC (E coli O157:H7, n = 8; E coli O111, n = 1; E coli O103, n = 1), and 62 had negative stool culture results. Children infected with STEC were older (8.5 vs 3 years, respectively) (P < .001) and more likely to have abdominal tenderness (83% vs 17%, respectively) than those in the other groups. D-Dimer concentrations had a 70% sensitivity and 55% specificity for differentiating children with STEC from those with another cause of bloody diarrhea and 75% sensitivity and 70% specificity in differentiating children with a bacterial etiology from those with negative stool culture results.
Conclusion: Clinical assessment and laboratory data cannot reliably exclude the possibility that children with bloody diarrhea have an STEC infection and are at consequent risk of developing hemolytic uremic syndrome. Abnormal D-dimer concentrations (>0.5 μg/mL) were insufficiently sensitive and specific for distinguishing patients with STEC from those with another bacterial cause of bloody diarrhea. However, this marker might be useful in identifying children whose bloody diarrhea is caused by a bacterial enteric pathogen.
Figures

Similar articles
-
Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.J Pediatr. 2021 Oct;237:34-40.e1. doi: 10.1016/j.jpeds.2021.06.048. Epub 2021 Jun 29. J Pediatr. 2021. PMID: 34197890 Clinical Trial.
-
Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.Arch Pediatr Adolesc Med. 2012 Oct;166(10):902-9. doi: 10.1001/archpediatrics.2012.471. Arch Pediatr Adolesc Med. 2012. PMID: 22869280
-
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236. Pediatrics. 2005. PMID: 15930195
-
Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.Med Mal Infect. 2018 May;48(3):167-174. doi: 10.1016/j.medmal.2017.09.012. Epub 2017 Oct 18. Med Mal Infect. 2018. PMID: 29054297 Review.
-
Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis.Kidney Int Suppl. 2009 Feb;(112):S29-32. doi: 10.1038/ki.2008.615. Kidney Int Suppl. 2009. PMID: 19180128 Review.
Cited by
-
Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy.Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):539-547. doi: 10.1007/s10096-019-03755-0. Epub 2019 Nov 27. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31776873 Free PMC article.
-
Prevalence of Escherichia coli O157:H7 and associated factors in under-five children in Eastern Ethiopia.PLoS One. 2021 Jan 28;16(1):e0246024. doi: 10.1371/journal.pone.0246024. eCollection 2021. PLoS One. 2021. PMID: 33508023 Free PMC article.
-
Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Southern Italy after Implementation of Symptom-Based Surveillance of Bloody Diarrhea in the Pediatric Population.Int J Environ Res Public Health. 2020 Jul 16;17(14):5137. doi: 10.3390/ijerph17145137. Int J Environ Res Public Health. 2020. PMID: 32708640 Free PMC article.
-
INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome.Toxins (Basel). 2025 Jun 5;17(6):282. doi: 10.3390/toxins17060282. Toxins (Basel). 2025. PMID: 40559860 Free PMC article. Review.
-
Point-of-care multiplex-PCR enables germ identification in haemolytic uremic syndrome 94 h earlier than stool culture.Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):643-645. doi: 10.1007/s10096-020-04060-x. Epub 2020 Oct 4. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33011905
References
-
- Holtz LR, Neill MA, Tarr PI. Acute bloody diarrhea: a medical emergency for patients of all ages. Gastroenterology 2009; 136:1887–98. - PubMed
-
- Klein EJ, Stapp JR, Clausen CR, et al. . Shiga toxin–producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 2002; 141:172–7. - PubMed
-
- Chandler WL, Jelacic S, Boster DR, et al. . Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 2002; 346:23–32. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical